ACADIA Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2015

Go back to ACADIA Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2015

Acadia Pharma (ACAD) Misses Q4 EPS by 7c

February 29, 2016 9:19 AM EST

Acadia Pharma (NASDAQ: ACAD) reported Q4 EPS of ($0.45), $0.07 worse than the analyst estimate of ($0.38). Revenue for the quarter came in at $17 thousand versus the consensus estimate of $60 thousand.

For earnings history and earnings-related data on Acadia Pharma (ACAD) click here.

... More